This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
April 28–29, 2026
Kerry Hotel Pudong, Shanghai, China| Digital Partnering May 6–7. 2026

Larry Cai
CBO at Defand Therapeutics
Presenter

Profile

Defand Therapeutics is a startup biotech with a patented target-oriented, cell-survival based, phenotypical high throughput screening platform, DEFUSE, which trail-blazes in searching of molecular glue degrader hits that can be developed into new therapeutics in oncology, immunology, neurodegeneration, metabolism, infection areas.

Agenda Sessions

  • Startup Spotlight Pitch Competition Sponsored by Pfizer

    09:05

At this event